(KLA dri been)
Hairy cell leukemia (injection only): Treatment of active hairy cell leukemia as defined by clinically significant anemia, neutropenia, thrombocytopenia, or disease-related symptoms.
Multiple sclerosis, relapsing (oral tablet only): Treatment of relapsing forms of multiple sclerosis (MS), including relapsing-remitting (RRMS) and active secondary progressive disease in adults who have had inadequate response or are intolerant to other therapies for multiple sclerosis.
Limitations of use: Not recommended for patients with clinically isolated syndrome.
Sign up for a 10-day FREE Trial now and receive full access to all content.